Potential Therapies Using Myogenic Stem Cells Combined with Bio-Engineering Approaches for Treatment of Muscular Dystrophies

Muscular dystrophies (MDs) are a group of heterogeneous genetic disorders caused by mutations in the genes encoding the structural components of myofibres. The current state-of-the-art treatment is oligonucleotide-based gene therapy that restores disease-related protein. However, this therapeutic ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Motohashi, Norio, Shimizu-Motohashi, Yuko, Roberts, Thomas C., Aoki, Yoshitsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769835/
https://www.ncbi.nlm.nih.gov/pubmed/31514443
http://dx.doi.org/10.3390/cells8091066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769835/
https://www.ncbi.nlm.nih.gov/pubmed/31514443
http://dx.doi.org/10.3390/cells8091066

Ejemplares similares